ICU Medical (NASDAQ:ICUI) Shares Gap Up – Should You Buy?

ICU Medical, Inc. (NASDAQ:ICUI)’s stock price gapped up before the market opened on Friday . The stock had previously closed at $142.95, but opened at $147.97. ICU Medical shares last traded at $149.9950, with a volume of 6,682 shares trading hands.

Wall Street Analyst Weigh In

Several analysts have issued reports on ICUI shares. KeyCorp lowered their price objective on shares of ICU Medical from $180.00 to $164.00 and set an “overweight” rating for the company in a research report on Monday, April 27th. Wall Street Zen raised shares of ICU Medical from a “hold” rating to a “buy” rating in a research report on Saturday, May 9th. Needham & Company LLC upgraded ICU Medical from a “hold” rating to a “buy” rating and set a $165.00 target price for the company in a research note on Wednesday, May 27th. Sanford C. Bernstein cut ICU Medical to a “market perform” rating in a research note on Monday, June 15th. Finally, BTIG Research started coverage on ICU Medical in a research note on Monday, June 15th. They set a “buy” rating and a $170.00 price objective for the company. Two research analysts have rated the stock with a Strong Buy rating, four have given a Buy rating, one has given a Hold rating and one has issued a Sell rating to the stock. According to data from MarketBeat, the stock has a consensus rating of “Moderate Buy” and a consensus price target of $168.40.

ICU Medical Trading Up 1.3%

The company has a debt-to-equity ratio of 0.60, a quick ratio of 1.17 and a current ratio of 2.34. The business’s 50 day moving average price is $131.05 and its 200-day moving average price is $138.36. The firm has a market cap of $3.77 billion, a price-to-earnings ratio of 81.54, a price-to-earnings-growth ratio of 2.00 and a beta of 0.77.

ICU Medical (NASDAQ:ICUI) last announced its quarterly earnings data on Thursday, May 7th. The medical instruments supplier reported $1.97 earnings per share for the quarter, beating the consensus estimate of $1.78 by $0.19. ICU Medical had a return on equity of 7.50% and a net margin of 2.15%.The firm had revenue of $525.77 million during the quarter, compared to analyst estimates of $520.65 million. During the same period in the previous year, the company earned $1.72 earnings per share. ICU Medical’s quarterly revenue was down 12.3% on a year-over-year basis. ICU Medical has set its FY 2026 guidance at 7.750-8.450 EPS. Equities analysts expect that ICU Medical, Inc. will post 6.5 EPS for the current year.

Insider Buying and Selling at ICU Medical

In other ICU Medical news, Director David C. Greenberg sold 2,424 shares of the stock in a transaction on Tuesday, May 12th. The shares were sold at an average price of $122.91, for a total transaction of $297,933.84. Following the sale, the director directly owned 7,960 shares of the company’s stock, valued at approximately $978,363.60. This represents a 23.34% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. Also, VP Virginia Ruth Sanzone sold 2,447 shares of ICU Medical stock in a transaction dated Thursday, May 14th. The shares were sold at an average price of $124.08, for a total transaction of $303,623.76. Following the completion of the transaction, the vice president directly owned 19,460 shares of the company’s stock, valued at $2,414,596.80. This trade represents a 11.17% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. Company insiders own 2.10% of the company’s stock.

Hedge Funds Weigh In On ICU Medical

A number of hedge funds and other institutional investors have recently bought and sold shares of ICUI. Hilton Head Capital Partners LLC bought a new position in shares of ICU Medical during the fourth quarter valued at approximately $32,000. Covestor Ltd lifted its holdings in shares of ICU Medical by 22.1% in the 4th quarter. Covestor Ltd now owns 696 shares of the medical instruments supplier’s stock worth $99,000 after purchasing an additional 126 shares during the last quarter. Strs Ohio boosted its position in ICU Medical by 60.0% during the 4th quarter. Strs Ohio now owns 800 shares of the medical instruments supplier’s stock valued at $114,000 after purchasing an additional 300 shares during the period. Rockefeller Capital Management L.P. boosted its position in ICU Medical by 21.6% during the 4th quarter. Rockefeller Capital Management L.P. now owns 823 shares of the medical instruments supplier’s stock valued at $117,000 after purchasing an additional 146 shares during the period. Finally, Kemnay Advisory Services Inc. bought a new position in ICU Medical during the 4th quarter worth $120,000. 96.10% of the stock is currently owned by institutional investors and hedge funds.

About ICU Medical

ICU Medical, Inc, together with its subsidiaries, develops, manufactures, and sells medical devices used in infusion therapy, vascular access, and vital care applications worldwide. Its infusion therapy products include needlefree products under the MicroClave, MicroClave Clear, and NanoClave brands; Neutron catheter patency devices; ChemoClave and ChemoLock closed system transfer devices, which are used to limit the escape of hazardous drugs or vapor concentrations, block the transfer of environmental contaminants into the system, and eliminates the risk of needlestick injury; Tego needle free connectors; Deltec GRIPPER non-coring needles for portal access; and ClearGuard, SwabCap, and SwabTip disinfection caps.